Dr. Mohana Roy, MD

Dr. Roy practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Roy's NPI, 1265812820, was assigned on June 8, 2015. Dr. Roy graduated from Albert Einstein College of Medicine in 2015. Dr. Roy holds California license A154975.

Dr. Roy's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Roy's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Roy is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Roy to 2 more hospitals and 1 medical group, each named with a free account. Dr. Roy's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Roy practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Roy's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Roy is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Roy's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists chronic anemia, chronic kidney disease, deep vein thrombosis (DVT), neuropathy, obesity, pneumonia, purpura and thrombocytopenia and vitamin b deficiency among the conditions Dr. Roy treats.

CMS data shows 742 Medicare services from Dr. Roy across 6 procedure codes in 2024, for 219 Medicare patients. Medicare paid $96,292 for them.

CMS counts 219 Medicare patients who saw Dr. Roy in 2024. The largest group is 75 to 84, with 91 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Roy's median patient age at 64, with 56% women.

In 2024, Dr. Roy wrote 444 Medicare Part D claims for 90 patients. 63% of them were for generic drugs. CMS names the drug for 231 of them, across 11 drugs with 11 or more claims each, at $1,606,492 in total drug cost. In 2023, CMS named 103 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Roy for performance year 2024, reported as part of a group. Dr. Roy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Roy as offering telehealth.

Dmand AI links 18 papers to Dr. Roy, published from 2011 to 2024. 2021 was the busiest year, with 4. The most frequent topics are Patient Reported Outcome Measures, Advance Care Planning and Machine Learning. Dr. Roy has published most often in JCO Oncol Pract. Dr. Roy's most frequent co-authors are Kavitha Jennifer Ramchandran, MD, Joel William Neal, MD, PhD and Heather Ann Wakelee, MD.

CMS Open Payments shows 11 general payments to Dr. Roy from 5 drug and device companies from 2022 to 2025. Consulting fees make up the largest share, 82% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $4,077.

Dr. Roy graduated from Albert Einstein College of Medicine in 2015.

Dr. Roy is in network with 5 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.